Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Monotherapy vs multiple-drug therapy: the experts debate.

Gish RG, Gholam PM.

Cleve Clin J Med. 2009 May;76 Suppl 3:S20-4. doi: 10.3949/ccjm.76.s3.05. No abstract available.

PMID:
19470429
2.

[Antiviral treatment of chronic hepatitis B: monotherapy or combination therapy].

Ren H.

Zhonghua Gan Zang Bing Za Zhi. 2008 Jun;16(6):401-3. Chinese. No abstract available.

PMID:
18578985
3.

[A primer on the management of antiviral resistance in chronic hepatitis B].

Doerig C, Sahli R, Telenti A, Moradpour D.

Rev Med Suisse. 2009 Jan 21;5(187):203-4, 206-8,. Review. French.

PMID:
19271431
4.

[Treatment of chronic hepatitis B].

Mauss S.

MMW Fortschr Med. 2008 Apr 28;150 Spec No 1:48-51. German. No abstract available.

PMID:
19031564
5.

[Clevudine therapy in patients with chronic hepatitis B].

Lee KS.

Korean J Hepatol. 2009 Jun;15(2):119-21. doi: 10.3350/kjhep.2009.15.2.119. Korean. No abstract available.

6.

[Therapy of HIV-HBV-coinfection].

Mauss S.

MMW Fortschr Med. 2009 Apr 30;151(18):49-50, 52-3. German. No abstract available.

PMID:
19769076
7.

Experts call for new trials of hepatitis B drugs: evidence needed to identify first-line treatment.

Traynor K.

Am J Health Syst Pharm. 2008 Dec 1;65(23):2184, 2186. doi: 10.2146/news080092. No abstract available.

PMID:
19020176
8.

Current and future antiviral agents for chronic hepatitis B.

Yuen MF, Lai CL.

J Antimicrob Chemother. 2003 Mar;51(3):481-5. Review. No abstract available.

PMID:
12615847
9.

Chronic hepatitis B.

Lok AS, McMahon BJ.

Hepatology. 2007 Feb;45(2):507-39. No abstract available. Erratum in: Hepatology. 2007 Jun;45(6):1347.

10.

Combination therapy for chronic hepatitis B: is two really better than one?

Shukla A, Abraham P.

J Assoc Physicians India. 2013 Nov;61(11):783-4. No abstract available.

PMID:
24974487
11.

[Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].

[No authors listed]

MMW Fortschr Med. 2009 May 28;151(22):38-9. German. No abstract available.

PMID:
19526965
12.

Chronic viral hepatitis.

Dakhil N, Junaidi O, Befeler AS.

Mo Med. 2009 Sep-Oct;106(5):361-5. Review.

PMID:
19902718
13.

Antiviral therapy for chronic hepatitis B: challenges in Hong Kong.

Chan HL.

J Hepatol. 2009 Dec;51(6):1088-90. doi: 10.1016/j.jhep.2009.09.019. Epub 2009 Oct 7. No abstract available.

14.

Guideline on prevention and treatment of chronic hepatitis B in China (2005).

Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association.

Chin Med J (Engl). 2007 Dec 20;120(24):2159-73. No abstract available.

PMID:
18167196
15.
16.

[Long-term clevudine therapy in nucleos(t)ide-naïve and lamivudine-experienced patients with hepatitis B virus-related chronic liver diseases].

Lee HJ, Eun JR, Lee CH, Hwang JS, Suh JI, Kim BS, Jang BK.

Korean J Hepatol. 2009 Jun;15(2):179-92. doi: 10.3350/kjhep.2009.15.2.179. Korean.

17.

Antiviral resistance and specifically targeted therapy for HCV (STAT-C).

Thompson AJ, McHutchison JG.

J Viral Hepat. 2009 Jun;16(6):377-87. Review.

PMID:
19472445
18.

Chronic hepatitis B: back to the future with HBsAg.

Moucari R, Lada O, Marcellin P.

Expert Rev Anti Infect Ther. 2009 Aug;7(6):633-6. doi: 10.1586/eri.09.57. No abstract available.

PMID:
19681689
19.

Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B.

Borgniet O, Parvaz P, Bouix C, Chevallier P, Trépo C, André P, Zoulim F.

J Med Virol. 2009 Aug;81(8):1336-42. doi: 10.1002/jmv.21519.

PMID:
19551826
20.

Tenofovir for the treatment of hepatitis B virus.

Jenh AM, Thio CL, Pham PA.

Pharmacotherapy. 2009 Oct;29(10):1212-27. doi: 10.1592/phco.29.10.1212. Review.

PMID:
19792994

Supplemental Content

Support Center